| P50 | author | Jeffrey Keller | Q73027689 |
| | Romina María Uranga | Q88183456 |
| | Donald K. Ingram | Q107733297 |
| P2093 | author name string | Indu Kheterpal | |
| | Sunita Gupta | |
| | Carmen Ruiz | |
| | Michelle Domingue | |
| | Paul J. Pistell | |
| | Annadora J. Bruce-Keller | |
| | Alecia G. Knight | |
| P2860 | cites work | The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications | Q24598812 |
| | Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome | Q28236356 |
| | Expression of free fatty acid receptor GPR40 in the neurogenic niche of adult monkey hippocampus | Q28260269 |
| | Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus | Q28315009 |
| | Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet | Q28572572 |
| | Leptin and the regulation of body weight in mammals | Q29615976 |
| | Dose translation from animal to human studies revisited | Q29618049 |
| | Identification and expression cloning of a leptin receptor, OB-R | Q29620255 |
| | HIV epidemiology and the effects of antiviral therapy on long-term consequences. | Q30372536 |
| | Development of a water-escape motivated version of the Stone T-maze for mice | Q30423669 |
| | Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents | Q33650149 |
| | Cognitive impairment following high fat diet consumption is associated with brain inflammation. | Q33665160 |
| | Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients | Q34064351 |
| | High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis | Q34249521 |
| | Body surface area as a determinant of pharmacokinetics and drug dosing | Q34273673 |
| | The metabolic toxicities of antiretroviral therapy | Q34342866 |
| | Combination of high fat diet and chronic stress retracts hippocampal dendrites | Q34343372 |
| | Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms | Q34421694 |
| | Diabetes, insulin resistance, and dementia among HIV-1-infected patients | Q34483421 |
| | The use of body surface area as a criterion of drug dosage in cancer chemotherapy. | Q34538988 |
| | Neuropsychiatric complications of antiretroviral therapy | Q34565848 |
| | Dementia and neurocognitive disorders due to HIV-1 infection | Q34602429 |
| | Obesity, diabetes and cognitive deficit: The Framingham Heart Study | Q34651098 |
| | Evaluation and management of dyslipidemia in patients with HIV infection | Q34743413 |
| | Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat | Q34786989 |
| | Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. | Q35002031 |
| | Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease | Q35104006 |
| | Human immunodeficiency virus-associated dementia: an evolving disease | Q35112016 |
| | Fat distribution in men with HIV infection | Q35194387 |
| | Associative and predictive biomarkers of dementia in HIV-1-infected patients | Q35606267 |
| | Triglycerides induce leptin resistance at the blood-brain barrier | Q44865501 |
| | Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. | Q44941279 |
| | Novel pathways of bile acid metabolism involving CYP3A4. | Q45263019 |
| | Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons | Q46531105 |
| | Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action | Q48018867 |
| | Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats | Q48445758 |
| | HIV protease inhibitors stimulate hepatic triglyceride synthesis. | Q51552200 |
| | Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. | Q51910225 |
| | Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. | Q52121551 |
| | HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998 | Q57446072 |
| | Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study | Q57506033 |
| | Effects of a Saturated Fat and High Cholesterol Diet on Memory and Hippocampal Morphology in the Middle-Aged Rat | Q63090237 |
| | Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion | Q69584539 |
| | The clinical pharmacokinetics of quinapril | Q69584556 |
| | Lopinavir/ritonavir: a review of its use in the management of HIV infection | Q73185154 |
| | Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study | Q73977354 |
| | HIV protease inhibitors block adipogenesis and increase lipolysis in vitro | Q74341382 |
| | Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals | Q74606824 |
| | Interactive relations of central versus total obesity and blood pressure to cognitive function | Q81363806 |
| | Adiponectin and HIV-lipodystrophy: taking HAART. | Q35636197 |
| | HIV dementia: an evolving disease | Q35972797 |
| | Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity. | Q36024373 |
| | Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. | Q36246132 |
| | Studies of the effects of high fat diets on cognitive function in a rat model | Q36283934 |
| | Leptin: a potential cognitive enhancer? | Q36295304 |
| | Obesity and hypertriglyceridemia produce cognitive impairment | Q36578894 |
| | Adiponectin as an anti-inflammatory factor | Q36753830 |
| | Metabolic issues associated with protease inhibitors | Q36831643 |
| | How HIV protease inhibitors promote atherosclerotic lesion formation | Q36948007 |
| | Leptin regulation of neuronal excitability and cognitive function | Q37007039 |
| | Accelerated cognitive aging in diabetic rats is prevented by lowering corticosterone levels | Q37009887 |
| | Lopinavir/ritonavir in the treatment of HIV-1 infection: a review. | Q37052827 |
| | Adipokines in obesity | Q37071474 |
| | Evolution of HIV dementia with HIV infection | Q37073653 |
| | Striatal lesions interfere with acquisition of a complex maze task in rats | Q37073858 |
| | The multiple facets of the fat tissue | Q37085945 |
| | Overview of adipose tissue and its role in obesity and metabolic disorders | Q37179054 |
| | HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model | Q37188672 |
| | Maternal obesity is necessary for programming effect of high-fat diet on offspring | Q37210851 |
| | Obesity and vulnerability of the CNS. | Q37234576 |
| | Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus | Q37240129 |
| | Impact of plasma lipids and time on memory performance in healthy elderly without dementia | Q37331853 |
| | Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy | Q37395461 |
| | Inherited lipodystrophies and hypertriglyceridemia | Q37507465 |
| | NeuroAIDS: an evolving epidemic. | Q37522377 |
| | HIV-associated lipodystrophy: from fat injury to premature aging | Q37733151 |
| | Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 pathway in microglia | Q38300225 |
| | Leptin induces interleukin-1beta release from rat microglial cells through a caspase 1 independent mechanism | Q38302876 |
| | Distributions of leptin receptor mRNA isoforms in the rat brain | Q38336839 |
| | Lipotoxic effects of triacylglycerols in J774.2 macrophages | Q40029374 |
| | Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation | Q40139481 |
| | Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. | Q40301086 |
| | HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure. | Q40477455 |
| | Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice | Q40903070 |
| | Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice | Q43556253 |
| | Plasma HDL levels highly correlate with cognitive function in exceptional longevity | Q44196790 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lopinavir | Q422585 |
| | ritonavir | Q422618 |
| | lopinavir/ritonavir | Q3836750 |
| P304 | page(s) | 334-342 | |
| P577 | publication date | 2010-10-21 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice | |
| P478 | volume | 88 | |